To the best of our knowledge, BKT140 was identified as the only CXCR4 antagonist possessing high cytotoxic/apoptotic properties in various solid cancer as well as lymphoma and leukemia cell lines so far [24,56,57]. The gene discussed is CXCR4; the disease is leukemia.